tm logo
LYBRANVO
REGISTERED

on 17 May 2023

Last Applicant/ Owned by

SANDOZ AG

Viaduktstrasse 3CH-4051 Basel

CH

Serial Number

2030991 filed on 24th Apr 2020

Registration Number

TMA1179935 registered on 17th May 2023

Registration expiry Date

24th Apr 2030

Correspondent Address

(Dipchand LLP)401 Bay Street, Suite 2100Toronto

ONTARIO

CA

M5H2Y4

LYBRANVO

Trademark usage description

pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; antiinflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, antibacterials, antivirals, antibiotics, systemic and topical antifungals.


Classification kind code

11

Mark Details


Serial Number

2030991

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 26th Jan 2022
Agent Changed
Submitted for opposition 22
on 17th Sep 2021
Search Recorded
Submitted for opposition 20
on 17th Sep 2021
Examiner's First Report
Submitted for opposition 223
on 17th Sep 2021
Total Provisional Refusal
Submitted for opposition 256
on 29th Mar 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 28th May 2020
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 27th May 2020
Created
Submitted for opposition 31
on 27th May 2020
Formalized
Submitted for opposition 228
on 24th Apr 2020
International Registration
Submitted for opposition 30
on 24th Apr 2020
Filed